Syra Health (NASDAQ:SYRA) Announces Quarterly Earnings Results, Beats Estimates By $0.11 EPS

Syra Health (NASDAQ:SYRA) posted its quarterly earnings results on Tuesday. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.11, reports. The company had revenue of $2.56 million for the quarter, compared to analyst estimates of $2.20 million. Syra Health had a negative return on equity of 131.94% and a negative net margin of 54.90%.

Syra Health Price Performance

Shares of SYRA stock traded up $0.01 during trading hours on Wednesday, reaching $0.94. 23,739 shares of the stock were exchanged, compared to its average volume of 41,524. Syra Health has a 12-month low of $0.06 and a 12-month high of $1.15. The firm has a market capitalization of $12.99 million, a P/E ratio of -1.44 and a beta of 2.91. The business’s fifty day moving average is $0.87 and its two-hundred day moving average is $0.53.

Syra Health Company Profile

Syra Health Corp. is a healthcare technology and services company focused on improving access, delivery and outcomes across the U.S. healthcare system. The company develops solutions for behavioral and mental health, population health management, healthcare education and workforce needs.

Its offerings are designed to support healthcare providers, government agencies, employers and other organizations. Syra Health combines technology, data and professional services to assist with areas such as care coordination, health education, clinical workforce development, behavioral health programs and population health initiatives.

Based in Carmel, Indiana, Syra Health was established in the early 2020s and serves clients in the United States.